Volume 18, Number 6—June 2012
Dispatch
Clostridium difficile Infection, Colorado and the Northwestern United States, 20071
Table
Sex/age, y | Kaiser Permanente populations |
Projected no. US infections |
|||
---|---|---|---|---|---|
Incident infections, no. | Incidence rate* (SE) | Whites | Total | ||
Female | |||||
20–29 | 12 | 3.1 (0.91) | 4,920 | 6,383 | |
30–39 | 31 | 6.1 (1.09) | 9,399 | 12,186 | |
40–49 | 45 | 7.2 (1.1) | 13,079 | 16,386 | |
50–59 | 80 | 11.5 (1.3) | 18,892 | 23,046 | |
60–69 | 96 | 21.3 (2.2) | 23,340 | 27,681 | |
70–79 | 119 | 42.0 (3.8) | 32,141 | 37,503 | |
>80 | 140 | 79.5 (6.7) | 42,559 | 48,015 | |
Male | |||||
20–29 | 8 | 2.4 (0.85) | 3,969 | 5,009 | |
30–39 | 18 | 3.9 (0.93) | 6,318 | 7,871 | |
40–49 | 29 | 5.2 (0.96) | 9,274 | 11,321 | |
50–59 | 62 | 10.1 (1.3) | 16,242 | 19,359 | |
60–69 | 67 | 16.7 (2.0) | 16,747 | 19,355 | |
70–79 | 73 | 31.1 (3.6) | 18,994 | 21,780 | |
>80 | 90 | 87.1 (9.2) | 25,941 | 28,980 | |
All | 870 | 14.9 (0.5) | 241,815 | 284,875 |
*Per 10,000 patient-years.
1This research was presented as a poster at the 2011 HMO Research Network Conference, Boston, Massachusetts, USA, on March 23, 2011, and at the 2011 International Conference on Pharmacoepidemiology and Therapeutic Risk Management Annual Meeting, Chicago, Illinois, USA, on August 16, 2011.
Page created: May 10, 2012
Page updated: May 10, 2012
Page reviewed: May 10, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.